Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Encore1 Neurocognitive Sub-Study
NCT01516060Phase 3Completed
- Sponsor
- The Kirby Institute
- Start
- Jan 2012
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of efavirenz in human immunodeficiency virus infection (HIV), sponsored by The Kirby Institute. Started Jan 2012; status: completed.
02
Drugs
efavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01516060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01516060.